Sounds like the 20k number is in vitro. (In a glass dish with cell cultures). In mice its 59 times more effective as without the targeting improvement. The targeting improvement seems to be specially developed for blood cancer (leukemia). Not a doctor, taking out of my ass.
Sounds like better targeting. Have you read the article?
Yes, I’m not a doctor though. So what does “better targeting” mean for cancer patients in real world?
I’m just trying to quantify that 20,000 improvement to make sense to me, a regular person, because it’s just a random number to me.
It certainly doesn’t mean we have cured cancer. Does it?
They make it sound like they have cured cancer in that sentence. But they haven’t.
So how much more effective is the drug?
Does it save 20x more patients compared to regular drugs?
Because it certainly doesn’t save 20,000% more patients.
Is it just a clicbait title? and that 20,000 improvement will only save 0.01% more cancer patients and cost 1000 times more?
Sounds like the 20k number is in vitro. (In a glass dish with cell cultures). In mice its 59 times more effective as without the targeting improvement. The targeting improvement seems to be specially developed for blood cancer (leukemia). Not a doctor, taking out of my ass.